Some international experts have also questioned the speed at which Russia approved its vaccine. "Normally you need a large number of people to be tested before you approve a vaccine," said Peter Kremsner from the University Hospital in Tuebingen, currently testing CureVac's COVID-19 vaccine in clinical trials. Duncan Matthews, a professor of intellectual property law at Queen Mary University of London, said news of a potential COVID-19 vaccine was to be welcomed, "but safety must be the priority". More than 100 possible vaccines are being developed around the world to try to stop the COVID-19 pandemic. At least four are in final Phase III human trials, according to WHO data.

Source: bd News24 August 11, 2020 08:37 UTC